Some users experience a plateau around weeks 10-12
Estrogen drops less skin hydration, elasticity, and collagen Thinner, drier skin more prone to cracks, irritation, and flare-ups Weakened immune response increased skin reactivity Perimenopause also involves fluctuating progesterone, which can create more irregular cycles and skin changes
Food and Drug Administration has flagged BPC-157 among bulk substances reviewed for compounding, and long-term human safety has not been established
Mood disturbances: Deficiency could contribute to mood fluctuations, encompassing depression, anxiety, and irritability
There is no anesthesia required, no needles, and no recovery time
Proper injection technique minimizes these reactions